Site Search
Search Results
Rep. White files legislation aimed at improving health outcomes for Ohioans
... access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by private health insurance and Medicaid programs, which Rep. White’s legislation would fix. “Dubbed ‘the right treatment at the right time,’ ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Advocates Call on Lawmakers to Increase Tobacco Prevention Efforts and Pass Biomarker Legislation to Enhance Access to Lifesaving Care
... addictive products in our state annually, well-funded, fact-based tobacco prevention programs are needed more than ever. “To improve access to care for those who hear the words “you have cancer,” ACS CAN also calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Over 76,000 Ohioans heard the words, “you ...
Expand Access to Biomarker Testing in Ohio
... and partners are working together to make sure more Ohioans can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing disparities in health outcomes by race, ethnicity, income, and geography. Insurance coverage for biomarker testing is failing to keep pace with innovations and ...
House Votes to Remove Barriers to Biomarker Testing
... Society Cancer Action Network (ACS CAN) in Ohio: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. We have heard countless stories of the difficulties patients face in attempting to ... and the Ohio House for approving this legislation. We urge the Senate to quickly follow suit and take this significant step towards improving health outcomes and lowering health care costs." In 2024, approximately 24,810 Ohioans will die from cancer. Improved access to biomarker testing can connect more patients to ...
Cancer Patients and Survivors Return to the Statehouse to Rally Legislators
... with their elected officials. They let their lawmakers know that Ohio can and must do better to reduce the toll of cancer and improve access to care for those Ohioans who have heard the words “you have cancer.” “This year, an estimated 74,140 Ohioans will be diagnosed with cancer, ... the right time,’ biomarker testing has been critical in improving cancer outcomes. Advocates also asked lawmakers to provide better access to care by passing co-pay accumulator legislation. Passing this legislation will require that all prescription drug payments made by patients, ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as ...
It is Time to Reduce the Burden of Cancer on Buckeyes
... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Furthermore, legislation to address copay ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Legislative Action Needed to Reduce the Burden of Cancer on Buckeyes
... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Furthermore, copay accumulator legislation ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...
Legislative Action Needed to Reduce the Burden of Cancer on Buckeyes
... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Furthermore, copay accumulator legislation ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...